Related Experiment Video

Updated: Apr 17, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

9.0K

The role of STAT3 in tumor-mediated immune suppression

Sherise D Ferguson1, Visish M Srinivasan, Amy B Heimberger

  • 1Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, 1400 Holcombe Blvd., Unit 442, Houston, TX, 77030, USA, sdferguson@mdanderson.org.

Journal of Neuro-Oncology
|February 22, 2015
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) drives cancer immunosuppression. This review explores STAT3

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Tumor-induced immune modulation is critical in cancer progression.
  • Signal transducer and activator of transcription 3 (STAT3) is a key mediator of immunosuppression.
  • STAT3 signaling pathways are frequently overactivated in various cancers.

Purpose of the Study:

  • To review the operational mechanisms of STAT3 within the immune system and tumor microenvironment.
  • To discuss therapeutic strategies targeting STAT3 for improved cancer patient outcomes.

Main Methods:

  • Literature review of STAT3 function in cancer immunity.
  • Analysis of STAT3 signaling pathways in the tumor microenvironment.
  • Evaluation of current and emerging STAT3-targeted therapies.

Main Results:

  • STAT3 activation in immune cells and tumor cells promotes an immunosuppressive environment.
  • Targeting STAT3 can potentially reverse immune suppression and enhance anti-tumor immunity.
  • Various therapeutic strategies are being developed to inhibit STAT3 signaling.

Conclusions:

  • STAT3 plays a pivotal role in cancer immune evasion and progression.
  • Inhibition of STAT3 represents a promising therapeutic avenue for cancer treatment.
  • Further research is needed to optimize STAT3-targeted therapies for clinical application.

More Related Videos

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

8.3K
Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

15.7K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K